Search Results - "Zacchei, A G"

Refine Results
  1. 1

    Disposition of radiolabeled imipenem and cilastatin in normal human volunteers by NORRBY, S. R, ROGERS, J. D, FERBER, F, JONES, K. H, ZACCHEI, A. G, WEIDNER, L. L, DEMETRIADES, L, GRAVALLESE, D. A, HSIEH, J. Y.-K

    Published in Antimicrobial Agents and Chemotherapy (01-11-1984)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Gender differences in toxicokinetics, liver metabolism, and plasma esterase activity: observations from a chronic (27-week) toxicity study of enalapril/diltiazem combinations in rats by Los, L E, Welsh, D A, Herold, E G, Bagdon, W J, Zacchei, A G

    Published in Drug metabolism and disposition (01-01-1996)
    “…Diltiazem (DTZ), a calcium channel blocker, and enalapril (EN), an angiotensin-converting enzyme inhibitor, are being developed as combination therapy for…”
    Get more information
    Journal Article
  3. 3

    Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys by Hucker, H B, Hutt, J E, White, S D, Arison, B H, Zacchei, A G

    Published in Drug metabolism and disposition (01-01-1983)
    “…The disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a new agent with potent anticonvulsant, central…”
    Get more information
    Journal Article
  4. 4

    Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists by Grossman, S J, DeLuca, J G, Zamboni, R J, Keenan, K P, Patrick, D H, Herold, E G, van Zwieten, M J, Zacchei, A G

    Published in Toxicology and applied pharmacology (01-10-1992)
    “…The effects of a racemic leukotriene antagonist (MK-0571) and its component enantiomers (L-668,018 and L-668,019) on hepatic peroxisome proliferation were…”
    Get more information
    Journal Article
  5. 5

    Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate by Tocco, D J, Breault, G O, Zacchei, A G, Steelman, S L, Perrier, C V

    Published in Drug metabolism and disposition (01-11-1975)
    “…5-(2'4'-Difluorophenyl) [carboxy-14C]salicyclic acid (MK-647) was quickly and completely absorbed in rats, dogs, and man. Peak levels of plasma radioactivity…”
    Get more information
    Journal Article
  6. 6

    Stereospecific HPLC method for the quantitation of the enantiomers of MK-0571, a potent leukotriene D4 receptor antagonist, in biological specimens by Lee, L L, Zacchei, A G

    Published in Chirality (New York, N.Y.) (1991)
    “…A stereospecific HPLC bioanalytical method was developed for quantitation of the enantiomers of MK-0571, a leukotriene D4 receptor antagonist. The procedure…”
    Get more information
    Journal Article
  7. 7

    Thiobenzamide-induced hepatotoxicity: effects of substituents and route of administration on the nature and extent of liver injury by Grossman, S J, Patrick, D H, Kornbrust, D, Smith, P F, Herold, E G, DeLuca, J G, Zacchei, A G

    Published in Toxicology and applied pharmacology (01-12-1991)
    “…Differences in the nature and extent of hepatic injury were examined after administration of para-substituted thiobenzamides to rats. In accordance with…”
    Get more information
    Journal Article
  8. 8

    Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys by Zacchei, A G, Dobrinska, M R, Wishousky, T I, Kwan, K C, White, S D

    Published in Drug metabolism and disposition (01-01-1982)
    “…The physiological disposition following intravenous dosing of the separate enantiomers of indacrinone-14C (I), and of their major metabolite,…”
    Get more information
    Journal Article
  9. 9

    The physiological disposition of the uricosuric-saluretic agent (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy)acetic acid (MK-196) in the rat, dog, and monkey by Zacchei, A G, Wishousky, T I

    Published in Drug metabolism and disposition (01-09-1976)
    “…The physiological disposition of a new saluretic-uricosuric agent, (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy)acetic acid (MK-196), was studied in the…”
    Get more information
    Journal Article
  10. 10

    Physiologic disposition and metabolism of an anti-ulcer agent, N-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)-N',N'-dimethylurea, in rats, dogs, and monkeys by Hucker, H B, Stauffer, S C, White, S D, Arison, B H, Zacchei, A G

    Published in Drug metabolism and disposition (01-01-1982)
    “…14C-N-(2-Diisopropylaminoethyl)-N-(4,6-dimethyl-2-dimethyl- 2-pyridyl)-N',N'-dimethylurea (I) was administered orally to dogs and rats and to rhesus, African…”
    Get more information
    Journal Article
  11. 11

    The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans by Vickers, S, Duncan, C A, Arison, B H, Davies, R O, Ferguson, R, Zacchei, A G

    Published in Drug metabolism and disposition (01-05-1980)
    “…Studies of the metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-[14C]cyanopyridine (I) have been performed in humans, dogs, and…”
    Get more information
    Journal Article
  12. 12

    Urinary metabolites of amitriptyline in the dog by Hucker, H B, Balletto, A J, Demetriades, J, Arison, B H, Zacchei, A G

    Published in Drug metabolism and disposition (01-03-1977)
    “…Dogs excreted approximately 45% of an oral dose of 14C-amitriptyline (30 mg/kg) in the urine in 24 hr. Two new urinary metabolites of the drug were identified…”
    Get more information
    Journal Article
  13. 13

    Toxicokinetic analysis of losartan during gestation and lactation in the rat by Spence, S. G., Zacchei, A. G., Lee, L. L., Baldwin, C. L., Berna, R. A., Mattson, B. A., Eydelloth, R. S.

    Published in Teratology (Philadelphia) (01-04-1996)
    “…Previous developmental and reproductive toxicity studies in rats with losartan, a potent AT1‐selective angiotensin II (AII) receptor antagonist, correlated…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    The biotransformation of (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee by Zacchei, A G, Wishousky, T I, Arison, B H, Fanelli, Jr, G M

    Published in Drug metabolism and disposition (01-09-1976)
    “…The metabolism of a novel polyvalent saluretic agent (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy)acetic acid (MK-196) was studied in the chimpanzee…”
    Get more information
    Journal Article
  15. 15

    Gas chromatographic determination of a diuretic-antihypertensive agent, (+/-)-[[6,7-dichloro-2-(4-fluorophenyl)-2-methyl-1-oxo-5-indanyl] oxy]acetic acid, in biological fluids by Weidner, L L, Zacchei, A G

    Published in Journal of pharmaceutical sciences (01-02-1984)
    “…A method for the measurement of a potential diuretic-antihypertensive agent, (+/-)-[[6,7-dichloro-2-(4-fluorophenyl)-2-methyl-1-oxo-5-indanyl] oxy]acetic acid,…”
    Get more information
    Journal Article
  16. 16

    The metabolism of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in chimpanzee and man by Zacchei, A G, Wishousky, T I, Arison, B H, Hitzenberger, G

    Published in Drug metabolism and disposition (01-05-1978)
    “…The metabolism of the polyvalent saluretic agent (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid was studied in chimpanzee and man. The…”
    Get more information
    Journal Article
  17. 17

    Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man by Zacchei, A G, Weidner, L L, Besselaar, G H, Raftery, E B

    Published in Drug metabolism and disposition (01-07-1976)
    “…The physiological disposition of a new orally active antiarrhythmic drug, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl)benzylamine…”
    Get more information
    Journal Article
  18. 18

    Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man by Hucker, H B, Stauffer, S C, Balletto, A J, White, S D, Zacchei, A G, Arison, B H

    Published in Drug metabolism and disposition (01-01-1978)
    “…The absorption, distribution, excretion, and metabolism of 3-(5 H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine (cyclobenzaprine) were…”
    Get more information
    Journal Article
  19. 19

    Epoxide metabolites of protriptyline in rat urine by Hucker, H B, Balletto, A J, Demetriades, J, Arison, B H, Zacchei, A G

    Published in Drug metabolism and disposition (01-03-1975)
    “…Two epoxide metabolites of 5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene (protriptyline) were identified in the urine of rats given 14-C-labeled drug…”
    Get more information
    Journal Article
  20. 20